CAITLYN FOX: Open Payments
NPI 1487141446 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 43 payments from 12 companies in 2025. Trend: 2023 $1,439 · 2024 $896 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $149 |
| AstraZeneca Pharmaceuticals LP | 6 | $139 |
| Regeneron Healthcare Solutions, Inc. | 5 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $92 |
| CSL Behring | 4 | $71 |
| GENZYME CORPORATION | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Genentech USA, Inc. | 2 | $38 |
| Optinose US, Inc. | 1 | $30 |
Products named: DUPIXENT, NUCALA, NEFFY, Xolair, FASENRA, CUVITRU, Haegarda, Xhance.
Industry payments across IL — which companies pay providers there.
